Breaking News Instant updates and real-time market news.

03:00
05/27/19
05/27
03:00
05/27/19
03:00

FX Update: Risk-off positioning have unwound some more in the forex markets

FX Update: Risk-off positioning have unwound some more in the forex markets, with the dollar, yen and Swiss franc all losing ground to most of the main currencies today. A rally of over 0.5% in AUD-JPY has led the way, which has extended the rebound-form-trend lows seen late last week. The cross hit a three-day high at 78.88. Yen underperformance lifted USD-JPY to an intraday high of 109.55. EUR-USD edged out an 11-day high at 1.1215, while EUR-JPY and EUR-CHF concurrently recouped recently lost ground. Sterling traded higher for a third consecutive trading day, with Cable posting a six-day high at 1.2747 while EUR-GBP descended to a five-day low. Markets are still adjusting to the changing seascape in UK politics following the announcement resignation of Prime Minister May last week. The list of candidates for new leader of the Conservative Party, and hence new prime minister, grew over the weekend, and include some that would rule out a no-deal Brexit scenario and those that favour it if necessary. UK and U.S. markets will be closed today, so volumes and commitment will be limited.

TODAY'S FREE FLY STORIES

Hot Stocks
Zentalis expects cash to fund operations into 2023 » 07:10
08/13/20
08/13
07:10
08/13/20
07:10
ZNTL

Zentalis

$32.42 /

-1.49 (-4.39%)

As of June 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

04/28/20
Fly Intel: Top five analyst initiations
04/28/20 Guggenheim
Guggenheim starts Zentalis at Buy, sees ZN-c5 as potentially best-in-class
04/28/20 Morgan Stanley
Morgan Stanley starts Zentalis at Overweight with $45 price target
04/28/20 SVB Leerink
SVB Leerink bullish on Zentalis, initiates with an Outperform
ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

  • 30
    Jul
  • 03
    Apr
ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

Earnings
Azek reports Q3 EPS (44c), consensus 10c » 07:10
08/13/20
08/13
07:10
08/13/20
07:10
AZEK

Azek

$34.05 /

+0.57 (+1.70%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZEK Azek
$34.05 /

+0.57 (+1.70%)

08/11/20 DA Davidson
Azek price target raised to $33 from $27 at DA Davidson
07/08/20
Fly Intel: Top five analyst initiations
07/08/20 Citi
Azek initiated with a Neutral at Citi
07/07/20 B. Riley FBR
B. Riley FBR starts Azek at Buy with $38 price target
  • 12
    Jun
AZEK Azek
$34.05 /

+0.57 (+1.70%)

AZEK Azek
$34.05 /

+0.57 (+1.70%)

Earnings
Zentalis reports Q2 EPS (78c), consensus (50c) » 07:10
08/13/20
08/13
07:10
08/13/20
07:10
ZNTL

Zentalis

$32.42 /

-1.49 (-4.39%)

"This quarter and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

04/28/20
Fly Intel: Top five analyst initiations
04/28/20 Guggenheim
Guggenheim starts Zentalis at Buy, sees ZN-c5 as potentially best-in-class
04/28/20 Morgan Stanley
Morgan Stanley starts Zentalis at Overweight with $45 price target
04/28/20 SVB Leerink
SVB Leerink bullish on Zentalis, initiates with an Outperform
ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

  • 30
    Jul
  • 03
    Apr
ZNTL Zentalis
$32.42 /

-1.49 (-4.39%)

Upgrade
ECN Capital upgraded to Outperform from Sector Perform at RBC Capital » 07:09
08/13/20
08/13
07:09
08/13/20
07:09
ECNCF

ECN Capital

$0.00 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECNCF ECN Capital
$0.00 /

+ (+0.00%)

ECNCF ECN Capital
$0.00 /

+ (+0.00%)

07/17/20 Raymond James
ECN Capital resumed with an Outperform rating at Raymond James
04/29/20 TD Securities
ECN Capital price target lowered to C$6 from C$7 at TD Securities
04/21/20 Scotiabank
ECN Capital price target lowered to C$4.50 from C$6 at Scotiabank
04/03/20 CIBC
ECN Capital downgraded to Neutral from Outperformer at CIBC
Hot Stocks
China Xiangtai Food launching hot pot franchise business » 07:09
08/13/20
08/13
07:09
08/13/20
07:09
PLIN

China Xiangtai Food

$1.19 /

+0.005 (+0.42%)

China Xiangtai Food plans…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLIN China Xiangtai Food
$1.19 /

+0.005 (+0.42%)

Hot Stocks
VBL Therapeutics expects cash to fund requirements into 3Q22 » 07:08
08/13/20
08/13
07:08
08/13/20
07:08
VBLT

VBL Therapeutics

$1.31 /

+ (+0.00%)

At June 30, 2020, VBL had…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VBLT VBL Therapeutics
$1.31 /

+ (+0.00%)

VBLT VBL Therapeutics
$1.31 /

+ (+0.00%)

11/14/19 Chardan
VBL Therapeutics upgraded to Buy with $3.25 price target at Chardan
11/14/19 Chardan
VBL Therapeutics upgraded to Buy from Neutral at Chardan
VBLT VBL Therapeutics
$1.31 /

+ (+0.00%)

Earnings
VBL Therapeutics reports Q2 EPS (14c), consensus (14c) » 07:08
08/13/20
08/13
07:08
08/13/20
07:08
VBLT

VBL Therapeutics

$1.31 /

+ (+0.00%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VBLT VBL Therapeutics
$1.31 /

+ (+0.00%)

VBLT VBL Therapeutics
$1.31 /

+ (+0.00%)

11/14/19 Chardan
VBL Therapeutics upgraded to Buy with $3.25 price target at Chardan
11/14/19 Chardan
VBL Therapeutics upgraded to Buy from Neutral at Chardan
VBLT VBL Therapeutics
$1.31 /

+ (+0.00%)

Downgrade
KB Home downgraded to Neutral on construction cost concerns at Seaport Global » 07:07
08/13/20
08/13
07:07
08/13/20
07:07
KBH

KB Home

$36.61 /

+0.62 (+1.72%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$36.61 /

+0.62 (+1.72%)

KBH KB Home
$36.61 /

+0.62 (+1.72%)

06:13 Today Seaport Global
KB Home downgraded to Neutral from Buy at Seaport Global
08/11/20 Credit Suisse
KB Home price target raised to $44 from $36 at Credit Suisse
08/06/20 KeyBanc
KB Home upgraded to Overweight at KeyBanc
08/06/20 KeyBanc
KB Home upgraded to Overweight from Sector Weight at KeyBanc
KBH KB Home
$36.61 /

+0.62 (+1.72%)

KBH KB Home
$36.61 /

+0.62 (+1.72%)

KBH KB Home
$36.61 /

+0.62 (+1.72%)

Recommendations
JOYY price target raised to $115 from $86 at Benchmark » 07:07
08/13/20
08/13
07:07
08/13/20
07:07
YY

JOYY

/

+

Benchmark analyst Fawne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YY JOYY
/

+

YY JOYY
/

+

07/10/20 JPMorgan
JOYY price target raised to 'Street high' $125 at JPMorgan
06/15/20 Credit Suisse
JOYY price target raised to $124 from $88 at Credit Suisse
05/21/20 Benchmark
JOYY price target raised to $86 from $78 at Benchmark
05/20/20 Morgan Stanley
Morgan Stanley upgrades JOYY to Overweight on stepping up monetization of Likee
YY JOYY
/

+

YY JOYY
/

+

YY JOYY
/

+

Upgrade
Conifex Timber upgraded to Outperform from Sector Perform at RBC Capital » 07:07
08/13/20
08/13
07:07
08/13/20
07:07
CFXTF

Conifex Timber

$0.00 /

+ (+0.00%)

RBC Capital analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CFXTF Conifex Timber
$0.00 /

+ (+0.00%)

CFXTF Conifex Timber
$0.00 /

+ (+0.00%)

04/16/20 RBC Capital
Conifex Timber downgraded to Sector Perform from Outperform at RBC Capital
03/12/20 RBC Capital
RBC Capital backs Outperform on Conifex Timber after Q4 results
Earnings
GrowGeneration sees FY21 revenue $245M-$260M, consensus $196.23M » 07:06
08/13/20
08/13
07:06
08/13/20
07:06
GRWG

GrowGeneration

$8.76 /

+0.16 (+1.86%)

Sees adjusted EBITDA for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

07/17/20 Lake Street
GrowGeneration price target raised to $9 from $7 at Lake Street
07/14/20 Oppenheimer
Oppenheimer bullish on GrowGeneration, initiates with an Outperform
07/14/20 Oppenheimer
GrowGeneration initiated with an Outperform at Oppenheimer
07/08/20 Alliance Global Partners
GrowGeneration price target raised to $10 from $8 at Alliance Global Partners
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

  • 30
    Jun
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

Hot Stocks
scPharmaceuticals reports Q2 EPS (39c), consensus (42c) » 07:06
08/13/20
08/13
07:06
08/13/20
07:06
SCPH

scPharmaceuticals

$7.94 /

-0.48 (-5.70%)

"The highlight since…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCPH scPharmaceuticals
$7.94 /

-0.48 (-5.70%)

SCPH scPharmaceuticals
$7.94 /

-0.48 (-5.70%)

05/13/20 SVB Leerink
scPharmaceuticals price target raised to $12 from $7 at SVB Leerink
05/13/20 H.C. Wainwright
scPharmaceuticals price target raised to $15 from $13 at H.C. Wainwright
10/15/19 H.C. Wainwright
scPharmaceuticals initiated with a Buy at H.C. Wainwright
SCPH scPharmaceuticals
$7.94 /

-0.48 (-5.70%)

  • 21
    May
SCPH scPharmaceuticals
$7.94 /

-0.48 (-5.70%)

Hot Stocks
Passage Bio expects cash balance to fund operations into 2023 » 07:06
08/13/20
08/13
07:06
08/13/20
07:06
PASG

Passage Bio

$14.82 /

-1.03 (-6.50%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

06/25/20 Goldman Sachs
Passage Bio downgraded to Neutral from Buy at Goldman Sachs
03/25/20
Fly Intel: Top five analyst initiations
03/25/20 Chardan
Passage Bio initiated with a Buy at Chardan
03/24/20
Fly Intel: Top five analyst initiations
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

  • 28
    Feb
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

Hot Stocks
Passage Bio announces anticipated upcoming milestones » 07:06
08/13/20
08/13
07:06
08/13/20
07:06
PASG

Passage Bio

$14.82 /

-1.03 (-6.50%)

Initiate a Phase 1/2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

06/25/20 Goldman Sachs
Passage Bio downgraded to Neutral from Buy at Goldman Sachs
03/25/20
Fly Intel: Top five analyst initiations
03/25/20 Chardan
Passage Bio initiated with a Buy at Chardan
03/24/20
Fly Intel: Top five analyst initiations
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

  • 28
    Feb
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

Earnings
Leap Therapeutics reports Q2 EPS (12c), consensus (18c) » 07:06
08/13/20
08/13
07:06
08/13/20
07:06
LPTX

Leap Therapeutics

$1.95 /

+0.07 (+3.72%)

Reports Q2 revenue $375K,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LPTX Leap Therapeutics
$1.95 /

+0.07 (+3.72%)

LPTX Leap Therapeutics
$1.95 /

+0.07 (+3.72%)

06/29/20 Piper Sandler
Leap Therapeutics initiated with an Overweight at Piper Sandler
02/10/20 Baird
Leap Therapeutics initiated with an Outperform at Baird
01/08/20 Raymond James
Raymond James upgrades Leap Therapeutics to Outperform on BeiGene deal
01/08/20 Raymond James
Leap Therapeutics upgraded to Outperform from Market Perform at Raymond James
LPTX Leap Therapeutics
$1.95 /

+0.07 (+3.72%)

  • 18
    Jun
LPTX Leap Therapeutics
$1.95 /

+0.07 (+3.72%)

Hot Stocks
Mosaic announces July sales revenue, volumes by business unit » 07:06
08/13/20
08/13
07:06
08/13/20
07:06
MOS

Mosaic

$17.41 /

-0.215 (-1.22%)

Mosaic announced its July…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MOS Mosaic
$17.41 /

-0.215 (-1.22%)

MOS Mosaic
$17.41 /

-0.215 (-1.22%)

08/10/20 Goldman Sachs
Mosaic price target raised to $17 from $14 at Goldman Sachs
07/15/20 Citi
Mosaic upgraded to Buy from Neutral at Citi
06/29/20
Fly Intel: Top five analyst upgrades
06/29/20 BofA
Mosaic upgraded to Buy from Underperform at BofA
MOS Mosaic
$17.41 /

-0.215 (-1.22%)

MOS Mosaic
$17.41 /

-0.215 (-1.22%)

MOS Mosaic
$17.41 /

-0.215 (-1.22%)

Earnings
GrowGeneration sees FY20 revenue $170M-$175M, consensus $143.46M » 07:05
08/13/20
08/13
07:05
08/13/20
07:05
GRWG

GrowGeneration

$8.76 /

+0.16 (+1.86%)

Adjusted EBITDA guidance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

07/17/20 Lake Street
GrowGeneration price target raised to $9 from $7 at Lake Street
07/14/20 Oppenheimer
Oppenheimer bullish on GrowGeneration, initiates with an Outperform
07/14/20 Oppenheimer
GrowGeneration initiated with an Outperform at Oppenheimer
07/08/20 Alliance Global Partners
GrowGeneration price target raised to $10 from $8 at Alliance Global Partners
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

  • 30
    Jun
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

Earnings
Passage Bio reports Q2 EPS (60c), consensus (57c) » 07:05
08/13/20
08/13
07:05
08/13/20
07:05
PASG

Passage Bio

$14.82 /

-1.03 (-6.50%)

"We have made…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

06/25/20 Goldman Sachs
Passage Bio downgraded to Neutral from Buy at Goldman Sachs
03/25/20
Fly Intel: Top five analyst initiations
03/25/20 Chardan
Passage Bio initiated with a Buy at Chardan
03/24/20
Fly Intel: Top five analyst initiations
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

  • 28
    Feb
PASG Passage Bio
$14.82 /

-1.03 (-6.50%)

Recommendations
Tencent price target raised to HK$575 from HK$560 at Benchmark » 07:05
08/13/20
08/13
07:05
08/13/20
07:05
TCEHY

Tencent

$0.00 /

+ (+0.00%)

Benchmark analyst Fawne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCEHY Tencent
$0.00 /

+ (+0.00%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

08/03/20 Morgan Stanley
Sohu.com named a Research Tactical Idea at Morgan Stanley
07/27/20 Barclays
Tencent price target raised to $75 from $63 at Barclays
07/14/20 Citi
Tencent price target raised to HK$649 from HK$541 at Citi
07/08/20 Mizuho
Tencent price target raised to HK$475 from HK$410 at Mizuho
TCEHY Tencent
$0.00 /

+ (+0.00%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

Earnings
GrowGeneration reports Q2 EPS 6c, consensus 5c » 07:05
08/13/20
08/13
07:05
08/13/20
07:05
GRWG

GrowGeneration

$8.76 /

+0.16 (+1.86%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

07/17/20 Lake Street
GrowGeneration price target raised to $9 from $7 at Lake Street
07/14/20 Oppenheimer
Oppenheimer bullish on GrowGeneration, initiates with an Outperform
07/14/20 Oppenheimer
GrowGeneration initiated with an Outperform at Oppenheimer
07/08/20 Alliance Global Partners
GrowGeneration price target raised to $10 from $8 at Alliance Global Partners
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

  • 30
    Jun
GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

GRWG GrowGeneration
$8.76 /

+0.16 (+1.86%)

General news
FX Update: The dollar is down for a second day » 07:05
08/13/20
08/13
07:05
08/13/20
07:05

FX Update: The dollar is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Brookfield reports Q2 EPS (43c), consensus 39c » 07:04
08/13/20
08/13
07:04
08/13/20
07:04
BAM

Brookfield

$33.82 /

-0.04 (-0.12%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAM Brookfield
$33.82 /

-0.04 (-0.12%)

BAM Brookfield
$33.82 /

-0.04 (-0.12%)

06/08/20 JPMorgan
Brookfield initiated with an Overweight at JPMorgan
04/08/20 TD Securities
Brookfield upgraded to Action List Buy from Buy at TD Securities
03/29/20 Keefe Bruyette
Brookfield downgraded to Market Perform from Outperform at Keefe Bruyette
03/11/20
Fly Intel: Top five analyst initiations
BAM Brookfield
$33.82 /

-0.04 (-0.12%)

BAM Brookfield
$33.82 /

-0.04 (-0.12%)

BAM Brookfield
$33.82 /

-0.04 (-0.12%)

Hot Stocks
Keros Therapeutics expects cash, cash equivalents to fund operations into 2H22 » 07:04
08/13/20
08/13
07:04
08/13/20
07:04
KROS

Keros Therapeutics

$36.40 /

+0.58 (+1.62%)

Keros' cash and cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

06/12/20 Piper Sandler
Keros Therapeutics' EHA data bode well for KER-050, says Piper Sandler
05/27/20 Piper Sandler
Keros Therapeutics price target raised to $45 from $35 at Piper Sandler
05/04/20
Fly Intel: Top five analyst initiations
05/04/20 H.C. Wainwright
Keros Therapeutics initiated with a Buy at H.C. Wainwright
KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

  • 08
    Apr
KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

Earnings
Keros Therapeutics reports Q2 EPS (62c), consensus (67c) » 07:04
08/13/20
08/13
07:04
08/13/20
07:04
KROS

Keros Therapeutics

$36.40 /

+0.58 (+1.62%)

Reports Q2 revenue $0,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

06/12/20 Piper Sandler
Keros Therapeutics' EHA data bode well for KER-050, says Piper Sandler
05/27/20 Piper Sandler
Keros Therapeutics price target raised to $45 from $35 at Piper Sandler
05/04/20
Fly Intel: Top five analyst initiations
05/04/20 H.C. Wainwright
Keros Therapeutics initiated with a Buy at H.C. Wainwright
KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

  • 08
    Apr
KROS Keros Therapeutics
$36.40 /

+0.58 (+1.62%)

Initiation
Truist starts TCR2 Therapeutics at Buy with $40 price target » 07:03
08/13/20
08/13
07:03
08/13/20
07:03
TCRR

TCR2 Therapeutics

$16.76 /

-0.09 (-0.53%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCRR TCR2 Therapeutics
$16.76 /

-0.09 (-0.53%)

TCRR TCR2 Therapeutics
$16.76 /

-0.09 (-0.53%)

08/12/20 Truist
TCR2 Therapeutics initiated with a Buy at Truist
08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
07/27/20 H.C. Wainwright
TCR2 Therapeutics price target raised to $33 from $19 at H.C. Wainwright
07/27/20 Roth Capital
TCR2 Therapeutics upgraded to Buy from Neutral at Roth Capital
TCRR TCR2 Therapeutics
$16.76 /

-0.09 (-0.53%)

  • 29
    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.